Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Romiplostim, Rituximab, and Dexamethasone in Frontline ITP
NCT04588194Phase 2Unknown
- Start
- Nov 2020
- Primary completion
- Nov 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of romiplostim in immune thrombocytopenia (ITP). Status: unknown.
02
Drugs
romiplostim
03
Conditions
immune thrombocytopenia (ITP)
Beyond the preview
Go deeper on NCT04588194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04588194.